Related Experiment Video
Updated: Sep 2, 2025

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Molecular Features Triggered by Antipsychotic Medication in Brain Cells
Lívia Ramos-da-Silva1, André S L M Antunes2
1Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas (UNICAMP), Campinas, SP, Brazil. l172407@dac.unicamp.br.
Current antipsychotics for schizophrenia have limitations. Recent research clarifies their mechanisms and molecular effects, exploring new therapeutic targets for improved schizophrenia treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Schizophrenia treatment relies heavily on antipsychotic drugs.
- Current antipsychotics have significant limitations and side effects.
- Their precise mechanisms of action and molecular targets are not fully understood.
Purpose of the Study:
- To review recent research (past 5 years) on antipsychotic drugs.
- To enhance understanding of their mechanism of action and molecular effects in brain cells.
- To explore potential new therapeutic targets and strategies for schizophrenia.
Main Methods:
- Literature review of studies published in the last five years.
- Analysis of research on antipsychotic drug mechanisms.
- Investigation of molecular features triggered by these drugs.
Main Results:
- Recent research has provided insights into antipsychotic drug actions.
- Understanding of molecular targets and effects has advanced.
- Identification of potential new therapeutic avenues is emerging.
Conclusions:
- Despite advances, a complete understanding of antipsychotic pharmacology is still developing.
- Further research is needed to overcome current treatment limitations.
- New therapeutic targets and strategies hold promise for future schizophrenia management.
More Related Videos
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis: Goals of Pharmacotherapy

